#	Pagina
attuale pagina	/open-h2020/projects/199955/index.html
-1	/open-h2020/projects/221910/index.html
-2	/open-h2020/projects/225704/index.html

Opendata, web and dolomites

EVA

EVA - patient ventilation beyond limits

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

EVA project word cloud

Explore the words cloud of the EVA project. It provides you a very rough idea of what is the project "EVA" about.

flagship eva innovative circulation academic netherlands billion 16 pressures manual blood ce ventilation thin ventilator ventinova device market meeting families launch world reg patients injury form stress entered expiration marketing sheer manufactured trials russia medical centers suction globally training patient instead tube opinion standard distributors conservative lung marking 500 ensured disposable sold close ireland first 400 thick 2011 2016 care demonstration reducing outcome assistance markets q3 usa automated organizing protected designed clinical mechanically careful invasive elective expiratory brand prevent countries workshops penetration basic lungs ventilate china full negative registrations executed leaders generation icu sessions patent emergency 2nd surgical ventrain catheter trl6

Project "EVA" data sheet

The following table provides information about the project.

Coordinator	VENTINOVA MEDICAL BV Organization address address: MEERENAKKERPLEIN 7 city: EINDHOVEN postcode: 5652 BJ website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Netherlands [NL]
Project website	https://www.ventinovamedical.com/successes-innovation-project-2/
Total cost	2˙397˙540 €
EC max contribution	1˙890˙000 € (79%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2. (PRIORITY 'Industrial leadership')
Code Call	H2020-FTIPilot-2015-1
Funding Scheme	IA
Starting year	2015
Duration (year-month-day)	from 2015-11-01 to 2018-10-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	VENTINOVA MEDICAL BV VENTINOVA MEDICAL BV Organization address address: MEERENAKKERPLEIN 7 city: EINDHOVEN postcode: 5652 BJ website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (EINDHOVEN)	coordinator	793˙261.00
2	UNIVERSITAETSKLINIKUM FREIBURG UNIVERSITAETSKLINIKUM FREIBURG Organization address address: HUGSTETTER STRASSE 49 city: FREIBURG postcode: 79106 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (FREIBURG)	participant	621˙250.00
3	UNITRON INNOTECH BV UNITRON INNOTECH BV Organization address address: ASVELDWEG 2 city: HENGELO postcode: 7556 BP website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (HENGELO)	participant	390˙999.00
4	REGION HOVEDSTADEN REGION HOVEDSTADEN Organization address address: KONGENS VAENGE 2 city: HILLEROD postcode: 3400 website: www.regionh.dk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DK (HILLEROD)	participant	63˙000.00
5	ASSISTANCE PUBLIQUE HOPITAUX DE PARIS ASSISTANCE PUBLIQUE HOPITAUX DE PARIS Organization address address: 3 AVENUE VICTORIA city: PARIS postcode: 75000 website: http://www.aphp.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	participant	21˙487.00

Map

Project objective

EVA - Expiratory Ventilation Assistance – , or expiration by suction, is an innovative method to mechanically ventilate patients and is a key step in ventilation towards less-invasive, tailored and improved patient care as it enables: 1. full ventilation through a thin catheter instead of a thick tube 2. low and – if needed – negative pressures in the lungs promoting blood circulation 3. controlling the expiration, reducing sheer stress, which may prevent lung injury and improve patient outcome.

The EVA technology has already been on the market for some years in its most basic form: the manual, disposable emergency ventilator Ventrain®. Since market launch in 2011, Ventrain® is now being sold by 16 distributors in over 20 countries. Ventinova’s flagship is the “EVA device”: a fully automated ventilator based on EVA technology meeting the emerging needs of less invasive, tailored and improved patient care. First is focused on the large markets of elective surgical procedures and emergency care (€ 400 M, globally) and in 2nd generation on ICU-ventilation (€ 500 M, globally), before becoming ‘standard care’ (€ 4.6 billion, globally). The device, currently at TRL6, is still in development and CE marking is expected in Q3 2016. Next to marketing activities, such as organizing workshops and training sessions, and careful selection and support of distributors, penetration of the conservative medical market should be ensured by demonstration of better and tailored patient care using EVA ventilation in pre-clinical studies and controlled clinical trials. These are to be designed and executed in close collaboration with Key Opinion Leaders of established and world leading academic medical centers.

The described technology and products are protected by 5 patent families and design and brand registrations. The products are manufactured in The Netherlands and a dedicated catheter in Ireland. After CE marking, large non-EU markets are to be entered (e.g. USA, China, Russia).

Deliverables

List of deliverables.
Reports of communication activities	Documents, reports	2019-09-06 09:01:40
Evaluation of benefit personalised care	Documents, reports	2019-09-06 09:01:40
Obtained FDA approval	Websites, patent fillings, videos etc.	2019-09-06 09:01:40
Submission for publication	Documents, reports	2019-09-06 09:01:40
Workshop organisation	Websites, patent fillings, videos etc.	2019-09-06 09:01:40
Annual showcasing	Websites, patent fillings, videos etc.	2019-09-06 09:01:40
Obtained CE marking	Websites, patent fillings, videos etc.	2019-09-06 09:01:40
Evaluation of lung protective effects	Documents, reports	2019-09-06 09:01:40
Evaluation of safe use in Pigs	Documents, reports	2019-09-06 09:01:40

Take a look to the deliverables list in detail: detailed list of EVA deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EVA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EVA" are provided by the European Opendata Portal: CORDIS opendata.